febuxostat has been researched along with potassium chloride in 1 studies
| Studies (febuxostat) | Trials (febuxostat) | Recent Studies (post-2010) (febuxostat) | Studies (potassium chloride) | Trials (potassium chloride) | Recent Studies (post-2010) (potassium chloride) |
|---|---|---|---|---|---|
| 818 | 133 | 710 | 18,040 | 395 | 1,764 |
| Protein | Taxonomy | febuxostat (IC50) | potassium chloride (IC50) |
|---|---|---|---|
| Sodium/potassium/calcium exchanger 4 | Homo sapiens (human) | 174000 | |
| Sodium/potassium/calcium exchanger 2 | Homo sapiens (human) | 280000 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arai, H; Ishimaru, Y; Kitamura, M; Maeda, K; Matsumura, K; Mori, T; Nishino, T; Obata, Y; Sohara, E; Uchida, S; Umene, R; Uramatsu, T | 1 |
1 other study(ies) available for febuxostat and potassium chloride
| Article | Year |
|---|---|
Bartter syndrome representing digenic-based salt-losing tubulopathies presumably accelerated by renal insufficiency.
Topics: Adult; Bartter Syndrome; Chloride Channels; Diagnosis, Differential; Drug Therapy, Combination; Febuxostat; Female; Gitelman Syndrome; Gout Suppressants; Heterozygote; Humans; Hyperuricemia; Hypokalemia; Mutation; Phenotype; Potassium Chloride; Renal Insufficiency; Solute Carrier Family 12, Member 1; Treatment Outcome | 2020 |